ZA200502464B - Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome. - Google Patents

Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome.

Info

Publication number
ZA200502464B
ZA200502464B ZA200502464A ZA200502464A ZA200502464B ZA 200502464 B ZA200502464 B ZA 200502464B ZA 200502464 A ZA200502464 A ZA 200502464A ZA 200502464 A ZA200502464 A ZA 200502464A ZA 200502464 B ZA200502464 B ZA 200502464B
Authority
ZA
South Africa
Prior art keywords
prevention
treatment
acquired immunodeficiency
immunodeficiency syndrome
synergistic compositions
Prior art date
Application number
ZA200502464A
Other languages
English (en)
Inventor
Sek Chung Fung
Original Assignee
Tanox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanox Inc filed Critical Tanox Inc
Publication of ZA200502464B publication Critical patent/ZA200502464B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA200502464A 2002-09-27 2005-03-24 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome. ZA200502464B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41406202P 2002-09-27 2002-09-27

Publications (1)

Publication Number Publication Date
ZA200502464B true ZA200502464B (en) 2005-11-01

Family

ID=32043337

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200502464A ZA200502464B (en) 2002-09-27 2005-03-24 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome.

Country Status (12)

Country Link
US (1) US20060121480A1 (xx)
EP (1) EP1543166A4 (xx)
JP (1) JP2006503849A (xx)
CN (3) CN101152574A (xx)
AP (1) AP2005003294A0 (xx)
AU (1) AU2003299085B2 (xx)
BR (1) BR0314711A (xx)
CA (1) CA2498483A1 (xx)
HK (1) HK1082923A1 (xx)
MX (1) MXPA05002851A (xx)
WO (1) WO2004028473A2 (xx)
ZA (1) ZA200502464B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60229677D1 (de) 2001-05-31 2008-12-11 Conjuchem Biotechnologies Inc Langwirkende Fusionspeptidinhibitoren gegen HIV-Infektion
US20080039532A1 (en) * 2004-05-06 2008-02-14 Dominique Bridon Compounds For Specific Viral Target
BRPI0715794A2 (pt) * 2006-08-17 2013-07-23 Hoffmann La Roche conjugado de anticorpo contra ccr5 e peptÍdeo antifusogÊnico
TW200817438A (en) * 2006-08-17 2008-04-16 Hoffmann La Roche A conjugate of an antibody against CCR5 and an antifusogenic peptide
CL2008002092A1 (es) * 2007-07-20 2009-05-29 Hoffmann La Roche Conjugado que contiene dos o mas peptidos antifusogenicos y un anticuerpo anti-cd-4; metodo de produccion; composicion farmaceutica que lo comprende; polipeptidos antifusogenicos y uso del conjugado para tratar infecciones viricas.
RU2517084C2 (ru) * 2010-08-06 2014-05-27 Олег Ильич Эпштейн Способ и средство для ингибирования продукции или усиления элиминации белка р24
CN106139150B (zh) * 2015-04-10 2019-10-08 复旦大学 一种艾滋病治疗性疫苗组合物及其应用
PT3286212T (pt) * 2015-04-24 2021-08-24 Viiv Healthcare Uk No 5 Ltd Polipéptidos dirigidos para fusão com hiv

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2094713A1 (en) * 1990-10-26 1992-04-27 Shermaine A. Tilley Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120
DE69126301T2 (de) * 1990-11-27 1998-01-02 Biogen, Inc., Cambridge, Mass. Hiv-induzierte synzytien blockierender anti-cd-4-antikörper
US6136310A (en) * 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
US5397703A (en) * 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
US5817767A (en) * 1993-02-24 1998-10-06 Progenics Pharmaceuticals, Inc. Synergistic composition of CD4-based protein and anti-HIV-1 antibody, and methods of using same
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
KR100571215B1 (ko) * 1995-06-07 2006-10-24 트라이머리스 인코퍼레이티드 복합적인치료요법을이용한hiv와다른바이러스감염의치료
US7122185B2 (en) * 2002-02-22 2006-10-17 Progenics Pharmaceuticals, Inc. Anti-CCR5 antibody

Also Published As

Publication number Publication date
CA2498483A1 (en) 2004-04-08
HK1082923A1 (en) 2006-06-23
AU2003299085B2 (en) 2008-04-10
CN101152573A (zh) 2008-04-02
WO2004028473A3 (en) 2004-12-09
BR0314711A (pt) 2005-07-26
MXPA05002851A (es) 2005-09-08
CN1685064A (zh) 2005-10-19
WO2004028473A2 (en) 2004-04-08
JP2006503849A (ja) 2006-02-02
US20060121480A1 (en) 2006-06-08
EP1543166A2 (en) 2005-06-22
AU2003299085A1 (en) 2004-04-19
CN101152574A (zh) 2008-04-02
AP2005003294A0 (en) 2005-06-30
CN100341573C (zh) 2007-10-10
EP1543166A4 (en) 2009-10-28

Similar Documents

Publication Publication Date Title
ZA200110504B (en) Dietary or pharmaceutical compositions for use for the prevention or treatment of hyperoxaluria.
AU2003205737A1 (en) Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
HRP20130602T1 (xx) Spojevi 2,4-pirimidindiamina za uporabu kod lijeäśenja ili spreäśavanja autoimunih bolesti
HK1152474A1 (en) Methods and compositions for the prevention and treatment of sepsis
EP1753777A4 (en) METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING HIV INFECTION WITH TRIM5a
ZA200407813B (en) Medicament for preventing and/or treating chronic rejection.
WO2004006858A3 (en) Compounds, compositions, and methods employing same
EG23626A (en) Synergistic seed treatment compositions
ZA200502464B (en) Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome.
IL158181A0 (en) N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
EP1476471A4 (en) FUNCTIONAL FOODS FOR THE TREATMENT, PROTECTION AND RESTORATION OF CONNECTIVE TISSUES
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
AU2003211610A1 (en) Pharmaceutical compositions for the treatment or prevention of osteoporosis
HUP0300990D0 (en) Synergistic combination for the prophylaxis and treatment of diabetes
AUPR809001A0 (en) Compositions for the treatment and prevention of plant pathogens
YU11904A (sh) Upotreba inhibitora il-18 kod poremećaja preosetljivosti
MXPA03006468A (es) Composiciones para la prevencion o tratamiento de hepatopatia.
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
EP1305017A4 (en) METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF SYNDROME X
AU2003291461A8 (en) Compositions for diabetes treatment and prophylaxis
EP1660007A4 (en) COMPOSITIONS FOR THE TREATMENT AND PROPHYLAXIS OF DIABETES
ZA200400480B (en) A synergistic pharmaceutical combination for the prevention or treatment of diabetes.
SI1408966T1 (sl) Sinergistične farmacevtske kombinacije za preprečevanje ali zdravljenje diabetesa
AU2003233186A1 (en) Pharmaceutical compositions with anti-tumour activity, in particular for the treatment of leukaemia and glioblastomas
ZA200105452B (en) Compositions for the treatment of malaria.